Excellent. I posted some time ago that TK had too much on his plate and that Directors/Area Managers were required for the US, Eurozone and Asia. Following the capital raising ResApp has the funds to expand globally and to bring the necessary approvals and product commercialisation timeframes forward in all markets. We have a huge first-mover advantage on this one and a strengthening product pipeline and I'm certain management will want to capitalise on this.
- Forums
- ASX - By Stock
- RAP
- Ann: Massachusetts General Hospital for US Clinical Study Site-RAP.AX
Ann: Massachusetts General Hospital for US Clinical Study Site-RAP.AX, page-77
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online